CureDuchenne, a global leader in funding and advancing research for Duchenne muscular dystrophy, today announced a second investment into Tevard Biosciences to support the advancement of the company's ...
Primary endpoint is rise from floor (RFF) velocity with multiple secondary endpoints to assess muscle and pulmonary function ...
Atossa Therapeutics, Inc. (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of significant unmet clinical need, today announced ...
CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, proudly announces ...
Strong Buy on WVE-N531 and WVE-006 catalysts, Phase data, and cash runway into 2028. Click for this WVE stock update.
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies ...
EMA primary endpoint qualification of Stride Velocity 95th centile for Duchenne muscular dystrophy: Vernon, France Wednesday, August 9, 2023, 15:00 Hrs [IST] Sysnav Healthcare ann ...
Solid Biosciences Inc (NASDAQ:SLDB) is one of the best gene therapy stocks to buy in 2026. The stock has been a big win for investors, having gained roughly 75% over the past six months and surged ...
A working group on the treatment of Duchenne muscular dystrophy patients will be created within the Georgian Patriarchate, ...
Columnist Shalom Lim is grateful for the opportunity to use his lived experience to do good work on behalf of people with DMD ...
A wearable robot weighing just under one kilogram improves knee function in children living with spinal muscular atrophy (SMA ...
The FIFA World Cup was billed as a way to draw tourists from around the world to Canada along with their money, and now the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results